Celecoxib CAS 169590-42-5

Khoom Piav Qhia:

Khoom Lub Npe: Celecoxib CAS TSIS TAU: 169590-42-5

Lub ntsiab lus:

4- [5- (4-methylphenyl) -3- (trifluoromethyl) pyrazol-1-yl] benzenesulfonamide;

4- (5-p-tolyl-3- (trifluoromethyl) -1H-pyrazol-1-yl) benzenesulfonamide;

1- (4-sulphamoylphenyl) -3-trifluoromethyl-5- (p-tolyl) -pyrazole;

Tshuaj& Lub Cev Muaj Zog:

Tsos: Dawb hmoov

Kev Ntsuas: ≥99.0%

Ceev: 1.43g/cm3

Kub Point: 529 ℃ ntawm 760 mmHg

Melting Point: 157-159 ℃

Flash Point: 273.7 ℃

Refractive Index: 1.605

Dej Solubility: 7mg/L (25 ℃)

Vapor Siab: 2.81E-11mmHg ntawm 25 ℃

Cia Lub Sijhawm: Khaws ntawm RT

Solubility: DMSO:> 20mg/ml

Cov Ntaub Ntawv Kev Nyab Xeeb:

Cov Lus Hais Txog Kev Nyab Xeeb: S22-S24/25-S28-S37/39

HS Code: 2935009090

RIDADR: UN 2811

Cov Ntsiab Lus Risk: R20/21/22

Cov lej phom sij: Xn

WGK Lub Tebchaws Yelemees: 3

Celecoxib yog tus xaiv cyclooxygenase-2 (COX-2) inhibitor. Los tiv thaiv. Siv los kho tsev neeg adenomatous polyposis. Celecoxib yog cov tshuaj tiv thaiv kab mob nonsteroidal (NSAID). Nws ua haujlwm los ntawm kev txo cov tshuaj hormones uas ua rau mob thiab mob hauv lub cev. Celecoxib yog siv los kho qhov mob lossis mob tshwm sim los ntawm ntau yam mob xws li mob caj dab, ankylosing spondylitis, thiab mob khaub thuas. Celecoxib kuj tseem siv rau hauv kev kho mob qog noj ntshav polyps hauv cov nyuv.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: celecoxib cas 169590-42-5, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: Dicyclanil CAS 112636-83-6
• Tom ntej: Nateglinide CAS 105816-04-4